Healthcare >> Analyst Interviews >> May 8, 2002

Investing In Biotechnology: Franklin Berger – Jp Morgan H&q

FRANKLIN M. BERGER is a Managing Director in the US Equity Research Department of J. P. Morgan H & Q, having joined the firm in 1998. He is a Senior Biotechnology Analyst and part of the Global Health Care Research team. He received his MBA from Harvard University and both his MA and BA degrees from Johns Hopkins University. In 2000, he became a Founding Fellow of the Biotechnology Study Center at New York University School of Medicine. Profile
TWST: How extensive is the coverage at JP Morgan in health care

and biotech? Where are the areas for emphasis your team?

Mr. Berger: The healthcare group is really quite all-encompassing

at JP